DONATE

Pere Roca-Cusachs

Group leader

IBEC staff gather for IBEC Day to mark the institute’s 20th anniversary

Over 200 people took part in IBEC Day 2026, an event designed to encourage sharing, connection and celebration in honour of the institute’s 20th anniversary.

How cells decide when to react could shape future treatments for cancer and fibrosis

Scientists from the Institute for Bioengineering of Catalonia (IBEC) and King’s College London have discovered that cells do not just sense mechanical forces but also measure how long those forces last before responding. The findings, published in Nature Materials, reveal a timing mechanism that allows cells to ignore brief mechanical noise while reacting to sustained changes, a process that is crucial in diseases such as cancer and fibrosis.

Scientists create living tissues capable of changing shape in a programmed manner

Researchers at the Institute for Bioengineering for Catalonia (IBEC), the Polytechnic University of Catalonia – BarcelonaTech (UPC) and the International Centre for Numerical Methods in Engineering (CIMNE) have developed a new strategy for ‘programming’ the shape of biological tissues in vitro. The study, published in the journal Science, is the first to demonstrate that it is possible to guide the forces and final shape of living tissue by controlling the orientation of its cells. The research opens the door to new applications in tissue engineering, biohybrid robotics, and the design of smart living materials.

BIST calls for reforms to turn scientific discoveries into European industry

The BIST Forum 2026 brought together scientists and representatives from academic, economic and social institutions to discuss how frontier research can help build Europe’s industries of the future. The event also announced the recipients of the BIST To the Mothers of Science and Ignite programmes.

IBEC and EMBL Barcelona co-organise a matchmaking workshop to explore synergies

Today, the Institute for Bioengineering of Catalonia (IBEC) and the European Molecular Biology Laboratory (EMBL) held a matchmaking workshop. The event brought together leading researchers from both centres to encourage the formation of new connections and promote scientific dialogue.

INTROPY: A new approach to cancer therapy by inhibiting mechanotransduction

IBEC senior researcher Pere Roca-Cusachs has been awarded an ERC Proof of Concept Grant. This is a prestigious grant awarded by the European Research Council to explore the commercial and societal potential of research projects carried out at European institutions. Roca-Cusachs’ project, INTROPY, focuses on the inhibition of mechanotransduction as a potential therapy against cancer or fibrosis.

IBEC and VHIR hold a collaboration day to promote synergies

The 1st Translational Collaboration Day between the Vall d’Hebron Institute of Research (VHIR) and the Institute of Bioengineering of Catalonia (IBEC), held on 21st November, was an opportunity to learn about the projects and research lines of both institutions and to promote interaction between professionals.

Viscosity of materials key to cell differentiation

An IBEC-led study has revealed how mesenchymal stem cells respond to the viscosity of their environment, a key aspect in their differentiation process. The research, published in Nature Communications, provides new insights that could revolutionise the design of biomaterials for regenerative medicine applications.

Bioengineering for Emergent and Advanced Therapies at the 17th IBEC Symposium

IBEC’s 17th Annual Symposium focused on ‘Bioengineering for Emergent and Advanced Therapies’, one of IBEC’s key application areas. Around 300 people attended the event, including local and international researchers. It was a multidisciplinary environment in which experts from other centres and the IBEC community itself had the opportunity to present their projects and share knowledge.